A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2001
11/01/2001	WO2001042263A3 Oligosaccharide mixture
11/01/2001	WO2001041762A3 Valdecoxib compositions
11/01/2001	WO2001041761A3 Valdecoxib compositions
11/01/2001	WO2001036641A3 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO
11/01/2001	WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001	WO2001035974A3 Aplidine treatment of cancers
11/01/2001	WO2001034640A3 Peptide (virip) which inhibits a circulating virus in humans and the use thereof
11/01/2001	WO2001032153A3 Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
11/01/2001	WO2001030329A3 Combinations of lamivudine and entecavir for treatment of hepatitis b virus infuction
11/01/2001	WO2001029025A3 Tyrosine kinase inhibitors
11/01/2001	WO2001028356A3 Food supplement for increasing lean mass and strength
11/01/2001	WO2001018161A3 Process for the preparation of conjugated linoleic acid (cla)
11/01/2001	WO2001017480A3 Methods and compositions for preventing and treating urinary tract disorders
11/01/2001	WO2000034483A3 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	WO2000024780A9 Compositions and methods for treating polycystic kidney disease
11/01/2001	US20010036955 Method of inhibiting angiogenesis
11/01/2001	US20010036952 Treatment of alopecia
11/01/2001	US20010036949 Pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal
11/01/2001	US20010036948 Administering a vascular alkylating compound; prevention restenosis
11/01/2001	US20010036947 Pipecolic acid derivative hair growth compositions and uses
11/01/2001	US20010036943 Mixture of analgesic and carrier
11/01/2001	US20010036936 Compositions and methods for treating osteoporosis
11/01/2001	US20010036932 Cardiovascular disorders
11/01/2001	US20010036919 Preventing airway mucus production by administration of EGF-R antagonists
11/01/2001	US20010036913 Administering anticoagulant and anticholesterol agent
11/01/2001	US20010036663 Selective expansion of target cell populations
11/01/2001	US20010036635 Cancer screening
11/01/2001	US20010036486 Administering to subject a therapeutically effective amount of Hypericum perforatum or active component thereof
11/01/2001	US20010036481 Modulation of release from dry powder formulations
11/01/2001	US20010036479 Having preferred particle size distribution characteristics; antidiabetic agent
11/01/2001	US20010036469 Opiate antagonist implant and process for preparation therefor
11/01/2001	US20010036468 Soft chewable multivitamin tablet comprising separated active ingredients
11/01/2001	US20010036462 Enhancing immunology response
11/01/2001	US20010036459 Cytotoxicity; therapeutic antibody
11/01/2001	US20010036451 Embolic compositions
11/01/2001	US20010036445 Method of making chewing gum containing colloidal bismuth subcitrate
11/01/2001	US20010036444 Anticancer agents
11/01/2001	US20010035648 Plumbing fitting with hub
11/01/2001	EP1144642A3 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	CA2407519A1 Daily treatment for erectile dysfunction using a pde5 inhibitor
11/01/2001	CA2407493A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
11/01/2001	CA2407448A1 The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals
11/01/2001	CA2407445A1 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo¬3,4-b\|-pyridines as cyclin dependent kinase inhibitors
11/01/2001	CA2407370A1 Heterocycles that are inhibitors of impdh enzyme
11/01/2001	CA2407084A1 Isolated human transporter proteins, nucleic acids and uses thereof
11/01/2001	CA2407081A1 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
11/01/2001	CA2407077A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/01/2001	CA2407021A1 Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies
11/01/2001	CA2406855A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	CA2406725A1 Edg8 receptor, its preparation and use
11/01/2001	CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	CA2406532A1 Macrocyclic ns-3 serine protease inhibitors of hepatitis c virus compri sing alkyl and aryl alanine p2 moieties
11/01/2001	CA2406272A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
11/01/2001	CA2406264A1 Protein phosphatases
11/01/2001	CA2406073A1 A protein kinase c variant to alter memory
11/01/2001	CA2406067A1 Compositions comprising the combination of a bile acid and a fibrate for use in therapies for hyperlipidaemia-associated disorders
11/01/2001	CA2405565A1 Compounds for treating fibromyalgia and chronic fatigue syndrome
11/01/2001	CA2405170A1 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001	CA2405103A1 Chemical modification of mammalian urine and blood
11/01/2001	CA2404970A1 Inhibition of abnormal cell proliferation with camptothecin and combinations including the same
10/2001
10/31/2001	EP1149903A1 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
10/31/2001	EP1149580A1 Use of heteroaryl substituted N-(Indole-2-Carbonyl-) amides for the manufacture of a medicament for the treatment of infection
10/31/2001	EP1149579A2 Use of an estrogen agonist/antagonist for treating female sexual dysfunction
10/31/2001	EP1149161A2 Ribozymes directed against the catalytic subunit of the human telomerase (htert)
10/31/2001	EP1149113A1 Use of agonists or antagonists of mip-3a in therapy
10/31/2001	EP1149111A1 Method and composition for angiogenesis inhibition
10/31/2001	EP1148889A2 Method of treating demyelinating inflammatory disease using ccr1 antagonists
10/31/2001	EP1148888A2 Treatment of erectile dysfunctions with a c-type natriuretic polypeptide (cnp) as monotherapy or in combination with phosphodiesterase inhibitors
10/31/2001	EP1148887A2 Regulation of anaesthesia
10/31/2001	EP1148880A2 Methods for restoring and/or enhancing accommodation in pseudo phakia
10/31/2001	EP1148877A1 Methods for inhibiting bone resorption
10/31/2001	EP1148872A1 Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor
10/31/2001	EP1108428A9 Compositions for and uses thereof for treating viral disease with phenylacetate and derivatives thereof
10/31/2001	EP0444181B1 C-erbb-2 external domain: gp75
10/31/2001	CN1320120A Ideno-, haphto- and benzocyclohepta dihydrothizole derivatives, the production thereof and their use as anorectic medicaments
10/31/2001	CN1320045A Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke
10/31/2001	CN1320042A Seletive treatment of endothelial somatostatin receptors
10/31/2001	CN1320037A Antiviral indoleoxoacetyl piperazine derivatives
10/31/2001	CN1320035A Antibiotic compositions for treatment of the eye, ear and nose
10/31/2001	CN1319674A Sieving method for inhibiting tumor compound and medicinal compositions containing same
10/31/2001	CN1319391A Active content contained floating form having polyacetic vinylester and polyvinyl pyrrolidone, its preparation and use
10/30/2001	US6310181 Adaptor protein FRS2 and related products and methods
10/30/2001	US6310100 Method of treating hypertension
10/30/2001	US6310072 Production of analgesic synergy by co-administration of sub-analgesic doses of a MU opioid agonist and a kappa-2 opioid agonist
10/30/2001	US6310050 Therapeutic use of compounds with β3-agonist activity
10/30/2001	US6310045 Compositions and methods for cancer immunotherapy
10/30/2001	US6310039 Tumor-inhibiting conjugates of proteins and polymers consisting of a suitable carrier system and cytostatic compounds
10/30/2001	US6309866 6-phosphogluconate dehydrogenase
10/30/2001	US6309819 Diagnostic and therapeutic system for Crohn's disease and Colitia ulcerosa
10/30/2001	US6309663 Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
10/30/2001	US6309644 Parasitic nematode transglutaminase proteins and uses thereof
10/30/2001	US6309643 Diagnosis and treatment of inflammatory bowel disease using microbial antigens.
10/30/2001	US6309623 Plurality of perforated microstructures having a mean aerodynamic diameter of less than 5 mum and comprising at least one bioactive agent wherein said suspension medium comprises at least one propellant
10/30/2001	CA2090700C Modified antibodies with controlled clearance time
10/28/2001	CA2345284A1 Blood pressure stabilization during hemodialysis
10/27/2001	CA2345180A1 Methods of treating obesity using a neurotensin receptor ligand
10/27/2001	CA2307168A1 Plumbing fitting with hub
10/25/2001	WO2001079843A2 Screening method for compounds
10/25/2001	WO2001079525A2 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
10/25/2001	WO2001079502A2 Vectors for gene therapy

1 ... 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 ... 1151